The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype
Open accessAbstract
BACKGROUND: Because chronic obstructive pulmonary disease (COPD) is a heterogeneous condition, the identification of specific clinical phenotypes is key to developing more effective therapies. To explore if the persistence of systemic inflammation is associated with poor clinical outcomes in COPD we assessed patients recruited to the well-characterized ECLIPSE cohort (NCT00292552). METHODS AND FINDINGS: Six inflammatory biomarkers in peripheral blood (white blood cells (WBC) count and CRP, IL-6, IL-8, fibrinogen and TNF-α levels) were quantified in 1,755 COPD patients, 297 smokers with normal spirometry and 202 non-smoker controls that were followed-up for three years. We found that, at baseline, 30% of COPD patients did not show evidence of systemic inflammation whereas 16% had persistent systemic inflammation. Even though pulmonary abnormalities were similar in these two groups, persistently inflamed patients during follow-up had significantly increased all-cause mortality (13% vs. 2%, p<0.001) and exacerbation frequency (1.5 (1.5) vs. 0.9 (1.1) per year, p<0.001) compared to non-inflamed ones. As a descriptive study our results show associations but do not prove causality. Besides this, the inflammatory response is complex and we studied only a limited panel of biomarkers, albeit they are those investigated by the majority of previous studies and are often and easily measured in clinical practice. CONCLUSIONS: Overall, these results identify a novel systemic inflammatory COPD phenotype that may be the target of specific research and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citationATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Standardization of Spirometry, 1994 Update. American Thoracic Society.
(1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663792 · Cited by 6,594
Lung volumes and forced ventilatory flows
Quanjer, P. H., Tammeling, G. J., Cotes, J. E., Pedersen, O. F., Peslin, R., & Yernault, J.-C. (1993) · European Respiratory Journal · doi:10.1183/09041950.005s1693 · Cited by 5,318
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034 · cited 1×
“. The emerging field of network medicine provides a platform to explore the complexity of apparently distinct phenotypes of a disease”
BackgroundRabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925 · cited 1×
“These observations are clinically relevant because the severity of airflow limitation has been used so far as the most important criteria to guide therapy in COPD [43], whereas our study shows that patients with similar levels of airflow limitation may have different outcomes depending on the presence or absence of pe…”
BackgroundSelf-citationHiggins, S. M. F., Macken, A. P., Cullen, W., Saunders, J., Dunne, C. P., & O’Gorman, C. S. (2013) · PubMed · doi:10.34961/9953 · Cited by 4,806
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015 · cited 1×
“The BODE index was calculated as previously described [23].”
MethodSelf-citation(1993) · PubMed · Cited by 3,827
Standardization of Spirometry — 1987 Update
Buist, A. S. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.5.1073 · Cited by 3,266
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D. A., Agusti, A., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,981
Self-citationMechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814 · cited 1×
“In contrast, the fact that persistently inflamed patients were more obese supports a potential systemic origin of inflammation [39], although other potential mechanisms, such as the presence of airway bacterial colonization [40] and/or sleep apnea syndrome overlap [41] cannot be excluded because they were not investig…”
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738 · cited 2×
“The inflammatory response is a complex network of many different cells and molecules [10,11].”
BackgroundRabe, K. F. (2007) · American Journal of Respiratory and Critical Care Medicine · Cited by 2,567
Buist, A. S., McBurnie, M. A., Vollmer, W. M., Gillespie, S., Burney, P., Mannino, D. M., Menezes, A. M., Sullivan, S. D., Lee, T. A., Weiss, K. B., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61377-4 · Cited by 2,366
Global burden of COPD: risk factors, prevalence, and future trends
Mannino, D. M., & Buist, A. S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61380-4 · Cited by 2,079
Gan, W. Q. (2004) · Thorax · doi:10.1136/thx.2003.019588 · Cited by 1,838
The global burden of disease, 1990–2020
Lopez, A. D., & Murray, C. C. J. L. (1998) · Nature Medicine · doi:10.1038/3218 · Cited by 1,614
A network-based analysis of systemic inflammation in humans
Program, I. A. H. R. T. I. L. S. C. R., Calvano, S. E., Xiao, W., Richards, D. R., Felciano, R. M., Baker, H. V., Cho, R. J., Chen, R. O., Brownstein, B. H., Cobb, J. P., et al. (2005) · Nature · doi:10.1038/nature03985 · Cited by 1,429 · cited 1×
“The inflammatory response is a complex network of many different cells and molecules”
BackgroundBiomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
Vasan, R. S. (2006) · Circulation · doi:10.1161/circulationaha.104.482570 · Cited by 1,212
Characterisation of COPD heterogeneity in the ECLIPSE cohort
the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators, Agusti, A., Calverley, P. M., Celli, B., Coxson, H. O., Edwards, L. D., Lomas, D. A., MacNee, W., Miller, B. E., Rennard, S., et al. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-122 · Cited by 1,157 · cited 6×
“We recruited into the ECLIPSE study 2164 patients with COPD, 337 smoking and 245 non-smoking controls [15].”
BackgroundMethodSelf-citationSystemic effects of chronic obstructive pulmonary disease
Agustí, A. G. N., Noguera, A., Sauleda, J., Sala, E., Pons, J., & Busquets, X. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00405703 · Cited by 1,045
Self-citationChronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
Han, M. K., Agusti, A., Calverley, P. M., Celli, B. R., Criner, G., Curtis, J. L., Fabbri, L. M., Goldin, J. G., Jones, P. W., MacNee, W., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200912-1843cc · Cited by 1,032
Self-citationEvaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)
Vestbo, J., Anderson, W., Coxson, H. O., Crim, C., Dawber, F., Edwards, L., Hagan, G., Knobil, K., Lomas, D. A., MacNee, W., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00111707 · Cited by 759
Self-citationMarin, J. M., Soriano, J. B., Carrizo, S. J., Boldova, A., & Celli, B. R. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200912-1869oc · Cited by 699
Self-citationFrom COPD to chronic systemic inflammatory syndrome?
Fabbri, L. M., & Rabe, K. F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61383-x · Cited by 635
C-reactive Protein As a Predictor of Prognosis in Chronic Obstructive Pulmonary Disease
Dahl, M., Vestbo, J., Lange, P., Bojesen, S. E., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-713oc · Cited by 543
Self-citationInflamm‐ageing and lifelong antigenic load as major determinants of ageing rate and longevity
De Martinis, M., Franceschi, C., Monti, D., & Ginaldi, L. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.02.055 · Cited by 492
Inflammation markers predicting frailty and mortality in the elderly
De Martinis, M., Franceschi, C., Monti, D., & Ginaldi, L. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2005.11.004 · Cited by 345
Gabrielsson, J., & Weiner, D. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-050-2_16 · Cited by 328
Patel, B. D., Coxson, H. O., Pillai, S. G., Agustí, A. G. N., Calverley, P. M. A., Donner, C. F., Make, B. J., Müller, N. L., Rennard, S. I., Vestbo, J., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-059oc · Cited by 326
Self-citationGarcia-Aymerich, J., Gomez, F. P., Benet, M., Farrero, E., Basagana, X., Gayete, A., Pare, C., Freixa, X., Ferrer, J., Ferrer, A., et al. (2011) · Thorax · doi:10.1136/thx.2010.154484 · Cited by 319
Wouters, E. F. M., Creutzberg, E. C., & Schols, A. M. W. J. (2002) · Chest · doi:10.1378/chest.121.5_suppl.127s · Cited by 301
Self-citationAgustí, A. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200701-004fm · Cited by 265
Self-citationSystemic inflammation in chronic obstructive pulmonary disease: a population-based study
EPI-SCAN Steering Committee, Garcia-Rio, F., Miravitlles, M., Soriano, J. B., Muñoz, L., Duran-Tauleria, E., Sánchez, G., Sobradillo, V., & Ancochea, J. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-63 · Cited by 264
DAHL, M., TYBJŒRG-HANSEN, A., VESTBO, J., LANGE, P., & NORDESTGAARD, B. G. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.6.2010067 · Cited by 260
Self-citationSystems medicine and integrated care to combat chronic noncommunicable diseases
Bousquet, J., Anto, J. M., Sterk, P. J., Adcock, I. M., Chung, K., Roca, J., Agusti, A., Brightling, C., Cambon-Thomsen, A., Cesario, A., et al. (2011) · Genome Medicine · doi:10.1186/gm259 · Cited by 248
Self-citationSin, D. D., Man, S. F. P., Marciniuk, D. D., Ford, G., FitzGerald, M., Wong, E., York, E., Mainra, R. R., Ramesh, W., Melenka, L. S., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1356oc · Cited by 212
Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study
Eagan, T. M. L., Ueland, T., Wagner, P. D., Hardie, J. A., Mollnes, T. E., Damås, J. K., Aukrust, P., & Bakke, P. S. (2010) · European Respiratory Journal · doi:10.1183/09031936.00088209 · Cited by 207
Self-citationSystemic Inflammation and COPD
Walter, R. E., Wilk, J. B., Larson, M. G., Vasan, R. S., Keaney, J. F., Lipinska, I., O'Connor, G. T., & Benjamin, E. J. (2008) · Chest · doi:10.1378/chest.07-0058 · Cited by 192
Agusti, A., Sobradillo, P., & Celli, B. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201009-1414pp · Cited by 186
Self-citationClinical Biochemistry: Metabolic and Clinical Aspects
(2014) · Elsevier eBooks · doi:10.1016/c2011-0-07946-2 · Cited by 174
An Integrative Systems Biology Approach to Understanding Pulmonary Diseases
Auffray, C., Adcock, I. M., Chung, K. F., Djukanović, R., Pison, C. M., & Sterk, P. J. (2010) · CHEST Journal · doi:10.1378/chest.09-1850 · Cited by 151
Current Controversies and Future Perspectives in Chronic Obstructive Pulmonary Disease
Agustí, A. G. N., & Vestbo, J. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0405pp · Cited by 118
Self-citationNIH Roadmap for Medical Research
National Cancer Institute (2020) · Definitions · doi:10.32388/e5otqv · Cited by 100
C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach
Dahl, M., Vestbo, J., Zacho, J., Lange, P., Tybjærg–Hansen, A., & Nordestgaard, B. G. (2010) · Thorax · doi:10.1136/thx.2009.131193 · Cited by 88
Self-citationNew Paradigms in the Pathogenesis of Chronic Obstructive Pulmonary Disease II
Sethi, S., Mallia, P., & Johnston, S. L. (2009) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200905-025ds · Cited by 71
Kolsum, U., Roy, K., Starkey, C., Borrill, Z., Truman, N., Vestbo, J., & Singh, D. (2009) · International Journal of COPD · doi:10.2147/copd.s5018 · Cited by 64
Self-citationCirculating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?
Man, S. F. P., Xing, L., Connett, J. E., Anthonisen, N. R., Wise, R. A., Tashkin, D. P., Zhang, X., Vessey, R., Walker, T., Celli, B. R., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00153207 · Cited by 61
Self-citationFacing a “Slow-Motion Disaster” — The UN Meeting on Noncommunicable Diseases
Rosenbaum, L. R., & Lamas, D. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1112235 · Cited by 52
Bulitta, J. B., & Holford, N. H. G. (2014) · Wiley eBooks · doi:10.1002/9781118445112.stat06889 · Cited by 9
Cited by
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485
Inflammatory mechanisms in patients with chronic obstructive pulmonary disease
Barnes, P. J. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.05.011 · Cited by 1,683
Treatable traits: toward precision medicine of chronic airway diseases
Agusti, A., Bel, E., Thomas, M., Vogelmeier, C., Brusselle, G., Holgate, S., Humbert, M., Jones, P., Gibson, P. G., Vestbo, J., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01359-2015 · Cited by 1,083
Self-citationVanfleteren, L. E. G. W., Spruit, M. A., Groenen, M., Gaffron, S., van Empel, V. P. M., Bruijnzeel, P. L. B., Rutten, E. P. A., Op ’t Roodt, J., Wouters, E. F. M., & Franssen, F. M. E. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201209-1665oc · Cited by 828
Self-citationChronic obstructive pulmonary disease
Barnes, P. J., Burney, P. G. J., Silverman, E. K., Celli, B. R., Vestbo, J., Wedzicha, J. A., & Wouters, E. F. M. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.76 · Cited by 734
Self-citation
Metadata
- Authors
- Agustí, A., Edwards, L. D., Rennard, S. I., MacNee, W., Tal-Singer, R., Miller, B. E., Vestbo, J., Lomas, D. A., Calverley, P. M. A., Wouters, E., Crim, C., Yates, J. C., Silverman, E. K., Coxson, H. O., Bakke, P., Mayer, R. J., Celli, B., & for the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-05-18
- Volume
- 7
- Issue
- 5
- Pages
- e37483
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2161713331
- Cited by
- 848
- References
- 51
- FWCI
- 64.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.